Regulatory Affairs Consulting Services: Navigating Compliance for Accelerated Market Access
Khoom Taw Qhia
Hauv lub vev xaib tsis sib xws ntawm cov kev tswj hwm thoob ntiaj teb, qhov kev pom zoo raws sij hawm tuaj yeem ua lossis rhuav tshem cov khoom lag luam muaj txiaj ntsig, cov kws tshaj lij Kev Tswj Xyuas Kev Pabcuam yog qhov tseem ceeb. Raws li lub hauv paus tseem ceeb ntawm peb CRO (Cov Kev Tshawb Fawb Kev Tshawb Fawb Lub Koom Haum) cov ntaub ntawv, peb cov kev pabcuam muab cov kev taw qhia zoo thiab kev ua haujlwm tau zoo los ua kom cov ntaub ntawv xa mus, ua kom muaj kev ua raws, thiab txo cov teeb meem rau biopharmaceutical, biotech, thiab cov cuab yeej kho mob tshiab. Ua ke nrog cov qauv kev hloov pauv los ntawm FDA, EMA, NMPA, thiab ICH, peb txuas qhov sib txawv ntawm kev tshawb fawb tshiab thiab kev tswj hwm kev muaj tiag, pab koj ua tiav kev pom zoo sai dua thiab muaj kev lag luam ruaj khov.
Ntsiab Qhov Zoo & Nta
Peb qhov kev sab laj mus dhau ntawm cov ntaub ntawv-nws yog kev sib koom tes ua haujlwm uas cia siab tias yuav hloov txoj cai thiab ua kom koj txoj hauv kev pom zoo. Nrog rau kev tsom mus rau Asia-Pacific thiab thoob ntiaj teb kev sib haum xeeb, peb xa cov tswv yim tsim nyog uas txo qis kev xa mus txog li 25%.
|
Advantage/Feature |
Kev piav qhia |
|
Elite Regulatory Expertise |
Cov neeg saib xyuas yav dhau los thiab cov thawj coj RA nrog 18+ xyoo dhau los, txhawb nqa 150+ cov ntaub ntawv hauv oncology, CNS, thiab kev kho noob caj noob ces. |
|
Integrated Digital Toolkit |
eCTD sau software, AI sib txawv tsom xam, thiab kev tswj xyuas kev txawj ntse platforms rau tiag tiag -cov lus qhia lub sijhawm taug qab zoo li ICH Q12. |
|
Ntiaj teb ncav cuag nrog Local Insight |
Hybrid kev txawj ntse bridging NMPA cov kev cai nrog EMA/FDA, ua kom 20% nrawm dua Tuam Tshoj-rau- kev lag luam thoob ntiaj teb nkag. |
|
Kev Ua Raws Cai |
Xaus-to- xaus kev soj ntsuam kev pheej hmoo thiab kev tshuaj xyuas tsis zoo, ua rau xoom qhov tsis txaus ntawm cov neeg siv khoom xa tuaj. |
|
Accelerated Submission Support |
Tag nrho cov ntaub ntawv sau ua ke nrog hyperlinked modules thiab validation, streamlining IND / NDA / MAAs rau txoj kev tawg. |
|
Lifecycle Management Focus |
Kev hloov pauv tsis tu ncua thiab rov ua dua tshiab nrog RWE kev koom ua ke, ua kom muaj kev ruaj ntseg tom qab- pom zoo ua raws. |
Yam khoom
Peb Cov Kev Pabcuam Kev Pabcuam Kev Pabcuam yog tsim los ua cov qauv hloov pauv, theem ua haujlwm kom haum rau koj qhov kev txhim kho theem, txij li kev npaj ntxov mus rau kev tswj xyuas lub neej:
Regulatory Strategy & Planning
Gap tsom xam thiab txoj hauv kev rau kev sib tw / kev txhawb nqa menyuam ntsuag.
Kev Npaj & Kev Sau Ntawv
eCTD/NeeS sau ntawv rau INDs, NDAs, thiab variations.
Agency Liaison & Response Management
Cov lus nug daws teeb meem thiab kev soj ntsuam xyuas.
Tshaj tawm -Kev Pom Zoo & Kev Tswj Xyuas Lub Neej
Type IA/IB/II variations and renewals.
Tshwj xeeb ATMP Consulting
Kev taw qhia rau kev kho mob siab heev raws li EMA CAT lossis FDA RMAT.
Cov Txheej Txheem Kev Tswj Xyuas Teeb Meem
Ad-hoc txhawb nqa rov qab los yog hloov kho sai.
Cov khoom siv
Cov kev pabcuam no siv thoob plaws thaj chaw kho mob thiab cov txheej txheem tswj hwm, ua kom yooj yim nkag mus rau thoob ntiaj teb:
Oncology & Targeted Therapies:Parallel filings rau qhov kev txiav txim siab nyob rau hauv immuno- kev sim oncology.
Tsis tshua muaj kab mob & Gene Therapies:Orphan cov tswv yim tshuaj nrog cov rooj sib tham txog kev tshawb fawb rau NMPA/EMA.
Biologics & Vaccines:CMC dossier alignment rau mRNA platforms thiab biosimilars.
Cov Khoom Siv Kho Mob & Txhaj Tshuaj:ISO 13485 Kev txhawb nqa rau cov cwj mem insulin lossis PFS systems.
Market Expansion Initiatives:Kev sib haum xeeb xa mus rau Tuam Tshoj- mus rau -EU/US kev hloov pauv.
Lifecycle Extensions:Cov ntawv sau hloov tshiab suav nrog RWE rau cov khoom siv kho mob ntev xws li tshuaj tiv thaiv coagulants.